Purpose Little evidence of increased thrombotic risk is available in COVID-19 patients. Our
purpose was to assess thrombotic risk in severe forms of SARS-CoV-2 infection. Methods All …

Introduction We recently reported a high cumulative incidence of thrombotic complications in
critically ill patients with COVID-19 admitted to the intensive care units (ICUs) of three Dutch …

Introduction In the first wave, thrombotic complications were common in COVID-19 patients.
It is unknown whether state-of-the-art treatment has resulted in less thrombotic complications …

Background Few data are available on the rate and characteristics of thromboembolic
complications in hospitalized patients with COVID-19. Methods We studied consecutive …

A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to
excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation …

Background Infection by the 2019 novel coronavirus (COVID-19) has been reportedly
associated with a high risk of thrombotic complications. So far information is scarce and …

Background Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed
to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute …

Background Coagulopathy is a common abnormality in patients with COVID‐19. However,
the exact incidence of venous thromboembolic event is unknown in anticoagulated, severe …

Background Coagulation abnormalities in COVID-19 patients accompanied with poor
prognosis. This study aimed to determine the prevalence and risk factors of thrombotic …